Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells

Feng Tian1, Yuyan Cheng2, Songlin Zhou1

  • 1F.M. Kirby Neurobiology Center, Boston Children's Hospital, and Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.

Neuron
|June 29, 2022
PubMed

Insights

Researchers identified key transcription factors that control neuronal death and axon regeneration after injury. Manipulating these factors protected retinal ganglion cells in a glaucoma model, offering new therapeutic strategies for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Neuronal death and axon regeneration are critical in neurodegenerative diseases but poorly understood.
  • Optic nerve crush (ONC) in mice causes significant retinal ganglion cell (RGC) death and fails to regenerate axons.

Purpose of the Study:

  • To identify transcription factors (TFs) that repress RGC survival and axon regeneration after ONC.
  • To understand the regulatory programs governing neuronal response to injury.

Main Methods:

  • Performed an in vivo CRISPR-Cas9 genome-wide screen of 1,893 transcription factors.
  • Utilized ATAC-seq and RNA-seq to profile epigenetic and transcriptional changes in injured RGCs.
  • Identified injury-responsive TFs and their downstream targets.

Main Results:

  • Converged on four TFs as critical regulators of RGC survival and axon regeneration.
  • ATF3/CHOP regulate innate immunity pathways; ATF4/C/EBPγ regulate intrinsic neuronal stress pathways.
  • Manipulation of these TFs demonstrated neuroprotection in a glaucoma model.

Conclusions:

  • Identified core transcription programs driving RGC degeneration after axonal injury.
  • Revealed specific TFs (ATF3/CHOP, ATF4/C/EBPγ) as key regulators of neuronal survival and regeneration.
  • Suggests novel therapeutic strategies targeting these TFs for neurodegenerative diseases like glaucoma.